2017 Annual Results of the Group

Europlasma today announces its results for the year ended December 31, 2017, approved by the Board of Directors on April 17, 2018 and audited by the Auditors.

Read the press release in French


Europlasma announces an agreement with European High Growth Opportunities Securitization Fund improving the conditions of the 3rd tranche of convertible bonds

In accordance with the bond financing agreement and the schedule published, the third warrant of convertible bonds into shares (BEOCA) has been automatically exercised by the investor, European High Growth Opportunities Securitization Fund.

Read the press release (in French)


EIB and Europlasma announce the signature of a € 30 million financing contract for the innovative CHO Tiper project

The European Investment Bank (EIB), the bank of the European Union (EU), has granted a € 30 million loan to finance the CHO Tiper renewable energy power plant developed by CHO Power, a subsidiary of Europlasma Group.

Read the press release (in French)


Europlasma announces a capital increase in its subsidiary CHO Power, valuing it at €101 million, and a simultaneous reorganisation of CHO Morcenx

Following the Final Acceptance of CHO Morcenx obtained in June 2017, Europlasma and GRAF (Gottex Real Asset Fund), which owned 65% of CHO Morcenx, reached an agreement to align their interests in order to consolidate the ambitious strategy growth of the Renewable Energies division CHO Power.

Read the press release


Europlasma commits alongside Arcelor Mittal to reducing the carbon footprint of the steel industry

Europlasma announces its participation in the "IGAR" (Reducing Gas Injection) proje

Read the press release


The European Investment Bank intends to support the CHO Tiper project by providing up to 30 million euro of debt financing

European Commissioner Carlos Moedas and Ambroise Fayolle, Vice President of the European Investment Bank (EIB), today announced the signature of a letter of intent to provide the CHO TIPER renewable energy project up to 30 million euro of debt financing.

Read the press release


General Meeting of shareholders on 26/10/2017

  • Approval of all Resolutions

On October 26, 2017 (by 2nd call), under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered its shareholders representing 37,956,617 shares (present, represented or postal votes), corresponding to 24.95% of the capital.

Read the release


2017 half-year Results as at 30 June 2017

Europlasma today announces its results for the six months ended June 30, 2017, which were subject to a limited review by Auditors and were approved by the Board of Directors on October 24, 2017.

Read the release


General Meeting of Shareholders, new call

On 10 October 2017, under the chairmanship of Pierre Catlin, the Extraordinary General Meeting of the Company gathered shareholders representing 30,253,122 shares (present, represented or postal votes), corresponding to 19.88% of the share capital.

Read the release